Publications by authors named "F Moosig"

Pain in the musculoskeletal system and therefore joint pain is one of the most common reasons for consulting a general practitioner (GP). Inflammatory rheumatic diseases are among the important differential diagnoses. However, the prevalence of rheumatological diseases is significantly lower than that of degenerative causes of pain.

View Article and Find Full Text PDF
Article Synopsis
  • - This article reviews updated treatment guidelines for Anti-Neutrophil Cytoplasmic Antibody (ANCA)-associated vasculitis (AAV) from major organizations including EULAR, KDIGO, and ACR, highlighting the role of glucocorticoids and biologics.
  • - Rituximab (RTX) is recommended for managing granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA), while anti-IL5 strategies are used for eosinophilic GPA (EGPA) in conjunction with glucocorticoids for non-organ-threatening cases.
  • - The article notes a trend towards lower doses of glucocorticoids and introduces avacopan as a
View Article and Find Full Text PDF

Objective: Previous studies suggested that distinct phenotypes of eosinophilic granulomatosis with polyangiitis (EGPA; formerly known as Churg-Strauss syndrome) could be determined by the presence or absence of antineutrophil cytoplasmic antibodies (ANCA), reflecting predominant vasculitic or eosinophilic processes, respectively. This study explored whether ANCA-based clusters or other clusters can be identified in EGPA.

Methods: This study used standardized data of 15 European centers for patients with EGPA fulfilling widely accepted classification criteria.

View Article and Find Full Text PDF

Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, characterized by asthma, eosinophilia and granulomatous or vasculitic involvement of several organs. The diagnosis and management of EGPA are often challenging and require an integrated, multidisciplinary approach. Current practice relies on recommendations and guidelines addressing the management of ANCA-associated vasculitis and not specifically developed for EGPA.

View Article and Find Full Text PDF